Ilex Medical (Israel) Performance
| ILX Stock | 5,990 70.00 1.18% |
The company retains a Market Volatility (i.e., Beta) of -0.13, which attests to not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Ilex Medical are expected to decrease at a much lower rate. During the bear market, Ilex Medical is likely to outperform the market. At this point, Ilex Medical has a negative expected return of -0.0173%. Please make sure to check out Ilex Medical's potential upside, and the relationship between the total risk alpha and daily balance of power , to decide if Ilex Medical performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Ilex Medical has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Ilex Medical is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
| Begin Period Cash Flow | 159.8 M | |
| Total Cashflows From Investing Activities | -82.5 M |
Ilex |
Ilex Medical Relative Risk vs. Return Landscape
If you would invest 612,200 in Ilex Medical on April 21, 2025 and sell it today you would lose (13,200) from holding Ilex Medical or give up 2.16% of portfolio value over 90 days. Ilex Medical is producing return of less than zero assuming 2.3074% volatility of returns over the 90 days investment horizon. Simply put, 20% of all stocks have less volatile historical return distribution than Ilex Medical, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Ilex Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Ilex Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Ilex Medical, and traders can use it to determine the average amount a Ilex Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0075
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ILX |
Estimated Market Risk
| 2.31 actual daily | 20 80% of assets are more volatile |
Expected Return
| -0.02 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Ilex Medical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Ilex Medical by adding Ilex Medical to a well-diversified portfolio.
Ilex Medical Fundamentals Growth
Ilex Stock prices reflect investors' perceptions of the future prospects and financial health of Ilex Medical, and Ilex Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Ilex Stock performance.
| Return On Equity | 0.19 | |||
| Return On Asset | 0.12 | |||
| Profit Margin | 0.12 % | |||
| Operating Margin | 0.18 % | |||
| Current Valuation | 901.49 M | |||
| Shares Outstanding | 11.19 M | |||
| Price To Book | 1.83 X | |||
| Price To Sales | 1.16 X | |||
| Revenue | 1.06 B | |||
| EBITDA | 307.85 M | |||
| Cash And Equivalents | 118.65 M | |||
| Cash Per Share | 11.80 X | |||
| Total Debt | 1.28 M | |||
| Debt To Equity | 38.00 % | |||
| Book Value Per Share | 51.14 X | |||
| Cash Flow From Operations | 270.68 M | |||
| Earnings Per Share | 9.75 X | |||
| Total Asset | 875.07 M | |||
About Ilex Medical Performance
By analyzing Ilex Medical's fundamental ratios, stakeholders can gain valuable insights into Ilex Medical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Ilex Medical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Ilex Medical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Ilex Medical Ltd engages in marketing, selling, and supporting equipment, disposables, and reagents for laboratories and healthcare establishments in Israel and South Africa. Ilex Medical Ltd was founded in 1977 and is based in Petah Tikva, Israel. Ilex Medical is traded on Tel Aviv Stock Exchange in Israel.Things to note about Ilex Medical performance evaluation
Checking the ongoing alerts about Ilex Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Ilex Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Ilex Medical generated a negative expected return over the last 90 days | |
| About 62.0% of the company shares are held by company insiders |
- Analyzing Ilex Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Ilex Medical's stock is overvalued or undervalued compared to its peers.
- Examining Ilex Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Ilex Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Ilex Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Ilex Medical's stock. These opinions can provide insight into Ilex Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Ilex Stock analysis
When running Ilex Medical's price analysis, check to measure Ilex Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ilex Medical is operating at the current time. Most of Ilex Medical's value examination focuses on studying past and present price action to predict the probability of Ilex Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ilex Medical's price. Additionally, you may evaluate how the addition of Ilex Medical to your portfolios can decrease your overall portfolio volatility.
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |